Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets

SIMPLE SUMMARY: Chronic lymphocytic leukemia harbors a high degree of genetic variability and interpatient heterogeneity. Some of the genetic alterations have an impact on the disease’s prognosis and evolution, but few data exist about the response to new approved targeted therapies in patients carr...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Oreja, Irene, Playa-Albinyana, Heribert, Arenas, Fabián, López-Guerra, Mónica, Colomer, Dolors
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269088/
https://www.ncbi.nlm.nih.gov/pubmed/34202439
http://dx.doi.org/10.3390/cancers13133150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269088/
https://www.ncbi.nlm.nih.gov/pubmed/34202439
http://dx.doi.org/10.3390/cancers13133150

Ejemplares similares